Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivatives
- 31 August 1982
- journal article
- Published by Elsevier BV in Mutation Research
- Vol. 95 (2-3), 105-118
- https://doi.org/10.1016/0027-5107(82)90250-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Cytogenetic toxicity of cyclophosphamide and its metabolites in vitroCytogenetic and Genome Research, 1980
- Urethane and hydroxyurethane induce sister-chromatid exchanges in cultured human lymphocytesMutation Research/Genetic Toxicology, 1979
- Teratogenic bioactivation of cyclophosphamideLife Sciences, 1979
- Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay systemMutation Research, 1979
- Detection of mutagenic derivatives of cyclophosphamide and a variety of other mutagens in a “microtitre”R fluctuation test, without microsomal activationMutation Research/Environmental Mutagenesis and Related Subjects, 1978
- A simplified technique for in vivo analysis of sister-chromatid exchanges using 5-bromodeoxyuridine tabletsCytogenetic and Genome Research, 1977
- Comparative in vivo mutagenicity testing by SCE and micronucleus induction in mouse bone marrowHuman Genetics, 1977
- In vivo BrdU-33258 Hoechst analysis of DNA replication kinetics and sister chromatid exchange formation in mouse somatic and meiotic cellsChromosoma, 1976
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975
- Observations on the mechanism of hydroxylation of cyclophosphamide by rat liver microsomes: The metabolism of cyclophosphamide-4-d2Journal of Mass Spectrometry, 1974